Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0JF6O
|
||||
| Former ID |
DIB014145
|
||||
| Drug Name |
Eltenac
|
||||
| Synonyms |
BY-820; B-788-20
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Arthritis [ICD9: 710-719; ICD10:M00-M25] | Discontinued in Phase 1 | [1] | ||
| Company |
ALTANA Pharma AG
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C12H9Cl2NO2S
|
||||
| Canonical SMILES |
N(c1c(csc1)CC(=O)O)c1c(Cl)cccc1Cl
|
||||
| CAS Number |
CAS 72895-88-6
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003785) | ||||
| REF 2 | Effect of eltenac in horses with induced endotoxaemia. Equine Vet J Suppl. 2000 Jun;(32):26-31. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.